Picture of BSF Enterprise logo

BSFA BSF Enterprise Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-30.97%
3m-52.31%
6m-42.13%
1yr-70.79%
Volume Change (%)
10d/3m-10.72%
Price vs... (%)
52w High-70.41%
50d MA-34.12%
200d MA-48.88%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-31.68%
Return on Equity-35.56%
Operating Margin-12135.32%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Sep 202430th Sep 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of BSF Enterprise EPS forecast chart

Profile Summary

BSF Enterprise PLC is a United Kingdom-based biotechnology company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people. 3DBT has three strands of three intellectual property (IP) each with a different sector focus development and revenue timeline. 3DBT’s City-mix is an animal-free cell growth agent for culturing skin, muscle and fat cells which are used for lab-grown meat and leather production. 3DBT’s Lipopeptide Etsyl actively increases collagen production in human skin cells which can be used in cosmetic and skin care products.

Directors

    Last Annual
    September 30th, 2023
    Last Interim
    September 30th, 2023
    Incorporated
    September 5th, 2018
    Public Since
    July 26th, 2019
    No. of Employees
    4
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    gb flag iconLondon Stock Exchange
    Shares in Issue
    103,336,937

    BSFA Share Price Performance

    Similar to BSFA

    Picture of Alliance Pharma logo

    Alliance Pharma

    gb flag iconLondon Stock Exchange

    Picture of Animalcare logo

    Animalcare

    gb flag iconLondon Stock Exchange

    Picture of Argent BioPharma logo

    Argent BioPharma

    gb flag iconLondon Stock Exchange

    Picture of AstraZeneca logo

    AstraZeneca

    gb flag iconLondon Stock Exchange

    Picture of Beximco Pharmaceuticals logo

    Beximco Pharmaceuticals

    gb flag iconLondon Stock Exchange

    FAQ